<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress.com" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>gavin-atkin &amp;laquo; WordPress.com Tag Feed</title>
	<link>http://wordpress.com/tag/gavin-atkin/</link>
	<description>Feed of posts on WordPress.com tagged "gavin-atkin"</description>
	<pubDate>Sat, 26 Jul 2008 05:44:40 +0000</pubDate>

	<generator>http://wordpress.com/tags/</generator>
	<language>en</language>

<item>
<title><![CDATA[Examples of Gavin Atkin's work online]]></title>
<link>http://gavinatkin.wordpress.com/2007/12/14/examples-of-gavin-atkins-work-online/</link>
<pubDate>Fri, 14 Dec 2007 09:07:08 +0000</pubDate>
<dc:creator>Gavin Atkin</dc:creator>
<guid>http://gavinatkin.wordpress.com/2007/12/14/examples-of-gavin-atkins-work-online/</guid>
<description><![CDATA[ PPIs bad for bones?
Osteoporosis patients who take a proton pump inhibitor (PPI) may be putting the]]></description>
<content:encoded><![CDATA[<p><i><b> PPIs bad for bones?</b></i><br />
Osteoporosis patients who take a proton pump inhibitor (PPI) may be putting themselves at increased risk of fracture, a study has shown. Co-prescribing a PPI for a post-menopausal osteoporosis sufferer who is taking a bisphosphonate increases his or her risk of hip fracture by 21 per cent compared to bisphosphonate monotherapy. <b><a href="http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id=259751&#38;CMPI_SHARED_articleId=266157&#38;CMPI_SHARED_CommentArticleId=266157&#38;CMPI_SHARED_ImageArticleId=266157&#38;CMPI_SHARED_ToolsArticleId=266157&#38;CMPI_SHARED_articleIdRelated=266157" title="PPIs may cancel out bisphosphonate benefits" target="_blank"> Click here to read more</a></b></p>
<p><i><b> Depressed women at much greater risk of low bone mass</b></i><br />
Depression is a significant risk factor for low bone mass in pre-menopausal women, and may be as important as smoking and reduced calcium intake, a study published by the Archives of Internal Medicine has suggested. <a href="http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id=259751&#38;CMPI_SHARED_articleId=270059&#38;CMPI_SHARED_CommentArticleId=270059&#38;CMPI_SHARED_ImageArticleId=270059&#38;CMPI_SHARED_ToolsArticleId=270059&#38;CMPI_SHARED_articleIdRelated=270059" title="Depressed women lose bone mass" target="_blank"><b>Click here to read more</b></a></p>
<p><i><b>Go ahead for Eisai appeal</b></i><br />
The Court of Appeal has granted permission for Eisai to appeal against a High Court ruling on Nice's decision not to recommend anti-dementia medicines including the company's drug donepezil (Aricept) in newly diagnosed Alzheimer's disease. <a href="http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id=259751&#38;CMPI_SHARED_articleId=271360&#38;CMPI_SHARED_ImageArticleId=271360&#38;CMPI_SHARED_articleIdRelated=271360&#38;CMPI_SHARED_ToolsArticleId=271360&#38;CMPI_SHARED_CommentArticleId=271360" title="Eisai apeal gets go-ahead" target="_blank"><b>Click here for more</b></a></p>
<p>Need a top-class medical journalist? Email me now at <b><a href="mailto:gmatkin@gmail.com">gmatkin@gmail.com</a></b>.</p>
]]></content:encoded>
</item>
<item>
<title><![CDATA[The revolution in prescribing will not be bloody or violent]]></title>
<link>http://gavinatkin.wordpress.com/2007/12/03/examples-of-gavin-atkin-work-online-2/</link>
<pubDate>Mon, 03 Dec 2007 08:16:20 +0000</pubDate>
<dc:creator>Gavin Atkin</dc:creator>
<guid>http://gavinatkin.wordpress.com/2007/12/03/examples-of-gavin-atkin-work-online-2/</guid>
<description><![CDATA[&nbsp;
Pharmafocus has just published a feature I wrote on the changes currently taking place in pre]]></description>
<content:encoded><![CDATA[<p class="snap_preview">&#160;</p>
<p><i>Pharmafocus</i> has just published a feature I wrote on the changes currently taking place in prescribing in the UK. While they are certainly revolutionary, I found they were unlikely to make a huge difference to most <b><a href="http://www.answers.com/topic/pharma-1?nafid=22" class="answerlink">pharma</a></b> marketers for some time to come:<b> </b></p>
<p><b>Reading some newspapers a few weeks ago, you might reasonably have imagined a war was going on. The GP newspaper <i>Pulse</i> revealed that nurse prescribing had nearly doubled during its first year, and the newspapers were full of doctors on the warpath. After reading the many harsh things said about the dangers of prescribing nurses, the reader might well have feared that thousands of inadequately-trained nurses were prescribing powerful drugs they knew little about. And industry strategists and analysts might reasonably have stopped for a moment to wonder whether 2007 would be the year pharma had to switch the focus of its marketing away from doctors and on to nurses. </b><b>In truth, there is a revolution going on <a href="http://www.pharmafocus.com/cda/focusH/1,2109,22-0-0-NOV_2007-focus_feature_detail-0-491685,00.html" title="A revolution in UK prescribing" target="_blank">Click here to read more</a></b></p>
<p>I’m available for freelance work at competitive rates. If you need a top-class medical journalist contact me by email at <b><a href="mailto:gmatkin@gmail.com"><font color="#8ab459">gmatkin@gmail.com</font></a>.</b></p>
]]></content:encoded>
</item>
<item>
<title><![CDATA[FDA investigates blockbuster anti-smoking drug]]></title>
<link>http://gavinatkin.wordpress.com/2007/11/23/varenicline-post-marketing-events-investigated-while-rimonabant-maker-replies-to-criticism/</link>
<pubDate>Fri, 23 Nov 2007 15:32:07 +0000</pubDate>
<dc:creator>Gavin Atkin</dc:creator>
<guid>http://gavinatkin.wordpress.com/2007/11/23/varenicline-post-marketing-events-investigated-while-rimonabant-maker-replies-to-criticism/</guid>
<description><![CDATA[FDA investigates varenicline adverse events
The US FDA is evaluating post-marketing adverse events a]]></description>
<content:encoded><![CDATA[<p><a href="http://gavinatkin.wordpress.com/wp-admin/tinyurl.com/37ds2g" target="_blank" title="FDA investigates varenicline adverse events"><b>FDA investigates varenicline adverse events<br />
</b></a>The US FDA is evaluating post-marketing adverse events after aggressive and erratic behaviour led to the death of an individual who took the drug in an attempt to quit smoking. <a href="http://gavinatkin.wordpress.com/wp-admin/tinyurl.com/37ds2g" target="_blank" title="FDA investigates varenicline events"><b>Click here to read more.</b></a></p>
<p>I'm available for freelance work at competitive rates. If you need accurate, authoritative writing or editing on these and other topics, contact me by email at <b><a href="mailto:gmatkin@gmail.com"><font color="#8ab459">gmatkin@gmail.com</font></a>.</b></p>
]]></content:encoded>
</item>
<item>
<title><![CDATA[The shocking rise of sexually transmitted infections]]></title>
<link>http://gavinatkin.wordpress.com/2007/11/22/examples-of-gavin-atkin%e2%80%99s-work-online/</link>
<pubDate>Thu, 22 Nov 2007 19:19:04 +0000</pubDate>
<dc:creator>Gavin Atkin</dc:creator>
<guid>http://gavinatkin.wordpress.com/2007/11/22/examples-of-gavin-atkin%e2%80%99s-work-online/</guid>
<description><![CDATA[In addition to my role as clinical and CPD editor at Chemist+Druggist, I also commission educational]]></description>
<content:encoded><![CDATA[<p>In addition to my role as clinical and CPD editor at <a href="http://www.chemistanddruggist.co.uk" target="_blank" title="Chemist+Druggist magazine"><b>Chemist+Druggist</b></a>, I also commission educational features for the pharmacy counter staff magazine <b><a href="http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id=72388&#38;CMPI_SHARED_articleId=72407&#38;CMPI_SHARED_CommentArticleId=72407&#38;CMPI_SHARED_ImageArticleId=72407&#38;CMPI_SHARED_ToolsArticleId=72407&#38;CMPI_SHARED_articleIdRelated=72407" target="_blank" title="OTC's Counterpart Plus">OTC's Counterpart Plus</a> </b>series.</p>
<p>Up to now I have usually commissioned other people to write these features, but when family problems made it difficult for one of our regular writers to turn in their copy on time, I stepped in at the last moment and wrote this <b><a href="http://tinyurl.com/yo6nfx" target="_blank" title="OTC's Counterpart Plus article on sexual health by Gavin Atkin">piece on sexual health</a></b>.</p>
<p><b>With the housing shortage, the credit crunch, and the state of the environment, you’d think today’s youngsters didn’t need anything else to worry about. But there is at least one other big issue they need to take very seriously indeed: sexually transmitted infections. We’re living in a new and very different world. A generation ago, no-one had heard of herpes or HIV, and chlamydia was still little known - but in young people today some of these infections are reaching frightening proportions, and bringing disease, infertility and, frequently, broken relationships and families. These are issues for older people too, but the spread of these diseases is far worse in the young.</b> <a href="http://tinyurl.com/yo6nfx" target="_blank" title="Sexual health article for Counterpart Plus by Gavin Atkin"><b>Click here to read on...</b></a></p>
<p>Could you use copy like this for your publication or website? If so, contact me by email at <b><a href="mailto:gmatkin@gmail.com">gmatkin@gmail.com</a>.</b></p>
<p><i><a href="http://www.chemistanddruggist.co.uk/c/document_library/get_file?folderId=72539&#38;name=DLFE-1110.pdf" target="_blank" title="Article on sexual health by Gavin Atkin"></a></i></p>
]]></content:encoded>
</item>
<item>
<title><![CDATA[The latest developments in pharmaceutical marketing]]></title>
<link>http://gavinatkin.wordpress.com/2007/11/17/features-on-pharmaceutical-marketing/</link>
<pubDate>Sat, 17 Nov 2007 15:23:15 +0000</pubDate>
<dc:creator>Gavin Atkin</dc:creator>
<guid>http://gavinatkin.wordpress.com/2007/11/17/features-on-pharmaceutical-marketing/</guid>
<description><![CDATA[Recent features on pharmaceutical marketing:
•UK clinical trials: on the mend?, Pharmafocus featur]]></description>
<content:encoded><![CDATA[<p>Recent features on pharmaceutical marketing:</p>
<p>•<b><a href="http://www.pharmafocus.com/cda/focusH/1,2109,22-0-0-OCT_2007-focus_feature_detail-0-491499,00.html">UK clinical trials: on the mend?</a></b>, <i>Pharmafocus</i> feature on the renaissance of clinical research in the UK<br />
•<b><a href="http://www.pharmafocus.com/cda/focusH/1,2109,22-0-0-AUG_2007-focus_feature_detail-0-491422,00.html">The NHS and pharma: Let's work together</a></b>, <i>Pharmafocus </i>feature on ways in which joint working can benefit both pharma and NHS organisations<i><br />
</i>•<b><a href="http://www.pharmafocus.com/cda/focusH/1,2109,22-0-0-MAY_2007-focus_feature_detail-0-491274,00.html">Med Ed comes of age</a></b>, <i>Pharmafocus </i>feature on medical education</p>
<p>Need a top class medical journalist? Contact me by email at <b><a href="mailto:gmatkin@gmail.com">gmatkin@gmail.com</a>.</b></p>
]]></content:encoded>
</item>

</channel>
</rss>
